PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature

SIMPLE SUMMARY: Radiolabeled choline and PSMA PET have been largely tested in the initial staging of prostate cancer and for biochemical recurrence. Moreover, diverse data are now available about their role in the evaluation of response to local and systematic therapies, and their predictive impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Alongi, Pierpaolo, Laudicella, Riccardo, Lanzafame, Helena, Farolfi, Andrea, Mapelli, Paola, Picchio, Maria, Burger, Irene A., Iagaru, Andrei, Minutoli, Fabio, Evangelista, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997431/
https://www.ncbi.nlm.nih.gov/pubmed/35406542
http://dx.doi.org/10.3390/cancers14071770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997431/
https://www.ncbi.nlm.nih.gov/pubmed/35406542
http://dx.doi.org/10.3390/cancers14071770

Ejemplares similares